BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35730371)

  • 21. THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV; Saenko V; Bazyka DA
    Probl Radiac Med Radiobiol; 2018 Dec; 23():283-301. PubMed ID: 30582853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma.
    Ke RS; Zhang K; Lv LZ; Dong YP; Pan F; Yang F; Cai QC; Jiang Y
    Int J Biol Macromol; 2019 May; 129():140-151. PubMed ID: 30731163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia.
    Zhou K; Zhang W; Zhang Q; Gui R; Zhao H; Chai X; Li Y; Wei X; Song Y
    Oncotarget; 2017 Apr; 8(15):25469-25481. PubMed ID: 28424416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
    Wu B; Słabicki M; Sellner L; Dietrich S; Liu X; Jethwa A; Hüllein J; Walther T; Wagner L; Huang Z; Zapatka M; Zenz T
    Br J Haematol; 2017 Nov; 179(3):421-429. PubMed ID: 28771672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
    Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
    Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
    Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
    Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism.
    Secchiero P; Melloni E; di Iasio MG; Tiribelli M; Rimondi E; Corallini F; Gattei V; Zauli G
    Blood; 2009 Apr; 113(18):4300-8. PubMed ID: 19190243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.
    Willander K; Dutta RK; Ungerbäck J; Gunnarsson R; Juliusson G; Fredrikson M; Linderholm M; Söderkvist P
    BMC Cancer; 2013 Jun; 13():274. PubMed ID: 23734977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
    Nadiminty N; Tummala R; Liu C; Lou W; Evans CP; Gao AC
    Mol Cancer Ther; 2015 Aug; 14(8):1884-95. PubMed ID: 26056150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
    De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
    Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Value of NOTCH1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
    Aref S; El-Agder M; Salama O; Abouzeid T; Sabry M
    Asian Pac J Cancer Prev; 2020 May; 21(5):1295-1301. PubMed ID: 32458636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice.
    Campregher PV; Hamerschlak N
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):271-6. PubMed ID: 24548608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
    Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
    Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia.
    Xu JJ; Yao FR; Jiang M; Zhang YT; Guo F
    Int J Mol Med; 2017 Feb; 39(2):415-422. PubMed ID: 28075457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYC copy number and mRNA expression in chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chornobyl NPP accident.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2020 Mar; 42(1):60-65. PubMed ID: 32231192
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Silva Barcelos EC; Rompietti C; Adamo FM; Dorillo E; De Falco F; Del Papa B; Baldoni S; Nogarotto M; Esposito A; Capoccia S; Geraci C; Sorcini D; Stella A; Arcaleni R; Tini V; Imbroisi Valle Errera F; Rosati E; Sportoletti P
    Front Oncol; 2023; 13():1218989. PubMed ID: 37817771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.
    Vavrova E; Kantorova B; Vonkova B; Kabathova J; Skuhrova-Francova H; Diviskova E; Letocha O; Kotaskova J; Brychtova Y; Doubek M; Mayer J; Pospisilova S
    Leuk Res; 2017 Sep; 60():145-150. PubMed ID: 28837890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
    Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
    Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.